3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Flushing: new trials by email Literature Review of Flushing trials Research Report on Flushing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis dimethyl fumarate, acetylsalicylic acid, ASA-Placebo - Relapsing-Remitting Multiple Sclerosis | Phase 4 | Completed | Biogen | 241 | 2014-05-01 | 2016-12-28 |
| Effects of Psyllium on Niacin Tolerability Psyllium, Aspirin - Flushing, Hyperlipidemias | Phase 4 | Completed | VA Greater Los Angeles Healthcare System | 26 | 2009-03-01 | 2017-12-12 |
| Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Quercetin, Placebo - Flushing | Phase 4 | Completed | University of Pennsylvania | 17 | 2009-02-01 | 2015-03-05 |
Dyslipidemias (1) · Hyperlipidemias (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Skin Manifestations (3) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Lipid Metabolism Disorders (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Nutritional and Metabolic Diseases (1)
Aspirin (2) · Dimethyl Fumarate (1) · Psyllium (1) · Quercetin (1) · isoquercitrin (1)
Biogen (1) · University of Pennsylvania (1) · VA Greater Los Angeles Healthcare System (1)
United States (2) · Ireland (1) · United Kingdom (1)
Freny V Mody, MD (1) · Richard L. Dunbar, MD (1)